Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Biomarker-guided rTMS for Treatment Resistant Depression

Phase 3

Recruiting

Conditions: Treatment Resistant Depression
Major Depressive Disorder

Interventions: Device: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2019-08-01

Last Posted Date: 2024-04-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 348

Registration Number: NCT04041479

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

PET Study of a2a Agonist Effects on the Ventricular CSF Clearance of [11C]Butanol

Early Phase 1

Withdrawn

Conditions: Healthy Volunteers

Interventions: Drug: Clonidine Pill

First Posted Date: 2019-07-25

Last Posted Date: 2021-07-20

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04032691

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies

Early Phase 1

Terminated

Conditions: Cancer
Neuro-Degenerative Disease

Interventions: Drug: Clonidine Pill

First Posted Date: 2019-07-24

Last Posted Date: 2021-06-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 3

Registration Number: NCT04030572

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Phase 2

Active, not recruiting

Conditions: Gastroesophageal Adenocarcinoma

Interventions: Drug: Nivolumab 240 MG

First Posted Date: 2019-07-16

Last Posted Date: 2024-12-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 80

Registration Number: NCT04021108

Locations: 🇺🇸
Roswell Park Cancer Center, Buffalo, New York, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 2 locations

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

Phase 2

Completed

Conditions: Ulcerative Colitis
Inflammatory Bowel Diseases

Interventions: Drug: Fecal Microbiota Transplantation
Dietary Supplement: Psyllium Husk Powder

First Posted Date: 2019-06-26

Last Posted Date: 2024-05-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 27

Registration Number: NCT03998488

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

Phase 4

Completed

Conditions: Nail Psoriasis
Nail Diseases

Interventions: Drug: Placebos
Drug: Triamcinolone Acetonide 5.0 mg/mL
Drug: Triamcinolone Acetonide 2.5 mg/mL
Drug: Triamcinolone Acetonide 7.5 mg/mL
Drug: Triamcinolone Acetonide 10 mg/mL

First Posted Date: 2019-06-19

Last Posted Date: 2024-03-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 11

Registration Number: NCT03991936

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Oral Iron in Children With Chronic Kidney Disease

Phase 4

Recruiting

Conditions: Chronic Kidney Insufficiency
Chronic Kidney Diseases

Interventions: Drug: Ferrous Sulfate

First Posted Date: 2019-06-19

Last Posted Date: 2024-09-30

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 60

Registration Number: NCT03991169

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Weill Cornell Medicine / New York Presbyterian Hospital, New York, New York, United States

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

Recruiting

Conditions: Bilateral Vocal Cord Paralysis

First Posted Date: 2019-06-10

Last Posted Date: 2024-06-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT03980275

Locations: 🇺🇸
Sean Parker Institute for the Voice, New York, New York, United States

GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Not Applicable

Withdrawn

Conditions: Psychological Feedback
Cancer
Liquid Tumor

Interventions: Behavioral: GIST

First Posted Date: 2019-05-22

Last Posted Date: 2024-02-15

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03959046

Locations: 🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Effect of Lifitegrast 5% on Tear Film Markers

Phase 4

Withdrawn

Conditions: Dry Eye Syndromes
Dry Eyes Chronic
Dry Eye

Interventions: Drug: Lifitegrast 5% Ophthalmic Solution

First Posted Date: 2019-05-16

Last Posted Date: 2021-02-16

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03952481

Locations: 🇺🇸
Weill Cornell Ophthalmology, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy